Michael J. Jeffries

Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ.

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD.

The American Association of Tissue Banks is a premier standard-setting body that promotes the safety and use of donated human tissue. The non-profit company is based in McLean, VA. Marc Pearce has been the CEO of the company since 2020. The organization ensures that safe and efficacious tissue products are available for patients in need. AATB offers professional development and networking opportunities for individuals and organizational collaborations, best practices, and an industry gold-standard accreditation program for institutions.